Drug Trial Radar · NCT00954707
CYPRESS - CYPHER for Evaluating Sustained Safety
Last checked: Nov 19, 2026Latest source record: Feb 7, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
2,509
Actual
Start
Aug 2009
Primary completion
Jan 2012
Study completion Mar 2016
Sponsor
- Lead sponsor
- Cordis US Corp.Industry
- Sponsor type
- Industry
- First posted
- Aug 7, 2009
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
CYPRESS: A Prospective,Randomized,Multi-Center,Double-Blind Trial to Assess the Effectiveness and Safety of Different Durations of Dual Anti-Platelet Therapy (DAPT) in Subjects Undergoing Percutaneous Coronary Intervention with the CYPHER® Sirolimus-eluting Coronary Stent (CYPHER® Stent)
Conditions
- Coronary Artery Disease
Interventions
Clopidogrel & Aspirin, Prasugrel & AspirinDrug
This population consists of subjects enrolled in the study who are free from death, MI, stroke, repeat coronary revascularization, major bleeding, and ST 12 months after stent implantation and who are compliant with 12 months of dual antiplatelet therapy following stent implantation and who are subsequently randomized to receive 18 months of thienopyridine treatment in addition to aspirin.
Placebo & AspirinDrug
This population consists of subjects enrolled in the study who are free from death, MI, stroke, repeat coronary revascularization, major bleeding, and ST 12 months after stent implantation and who are compliant with 12 months of dual antiplatelet therapy following stent implantation and who are subsequently randomized to receive 18 months of placebo treatment in addition to aspirin.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Phase I: the Rate of Target Lesion Failure (TLF)Time frame: 12 months
Locations
1 site in 1 country. Site status is shown where the registry gives one.
University Hospitals, Case Medical Center (Cleveland)
Cleveland, Ohio
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.